Serum HMGB1 and soluble urokinase plasminogen activator receptor levels aid diagnosis and prognosis prediction of sepsis with acute respiratory distress syndrome.
Sign Up to like & getrecommendations! Published in 2023 at "Biomarkers in medicine"
DOI: 10.2217/bmm-2022-0899
Abstract: Objective: To study the clinical application of serum HMGB1 and soluble urokinase plasminogen activator receptor (suPAR) expression in sepsis with acute respiratory distress syndrome (ARDS). Methods: Clinical data of 303 septic patients with/without ARDS were… read more here.
Keywords: sepsis; diagnosis; serum hmgb1; hmgb1 supar ... See more keywords